Key prevalence data, Sweden (Source: ITS/FSI study 2001/2002) MALES FEMALES (n=3205) (n=3507) Daily Daily Daily Daily smoking snus use smoking snus use.

Slides:



Advertisements
Similar presentations
Cutting Edge Research Joseph R DiFranza, MD Department of Family Medicine and Community Health University of Massachusetts Medical School.
Advertisements

Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
1 Olutola Bukola G, Ayo-Yusuf OA University of Pretoria & Office of the Director, School of Oral Health Sciences, University of Limpopo, Medunsa Campus,
Reducing the toll of smoking-related disease and death: The case for tobacco harm reduction The rationale for establishing low-toxicity smokeless nicotine.
Cross-sectional study. Definition in Dictionary of pharmaceutical medicine 2009 by G Nahler Dictionary of pharmaceutical medicine cross-sectional study.
Information on tobacco packages could encourage and help tobacco users to stop using tobacco or find least possible harmful ways of use for those unable.
Who tries how? Quit attempts among Swedish smokers Lars M. Ramström Institute for tobacco studies Stockholm, Sweden 6th Annual Conference of the SRNT Europe.
Through With Chew Week.
HIGHLIGHTS FROM THE CALIFORNIA TOBACCO SURVEYS Elizabeth A. Gilpin, MS Principal Investigator 1999 California Tobacco Surveys Cancer Prevention and Control.
Cancer Statistics 2013 A Presentation from the American Cancer Society
Cancer inequalities in Europe Kielce, Polish conference on cancer, 13/15 June 2011 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit.
Current challenges in tobacco prevention – do new products pose threats or opportunities? Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden.
Cancer Statistics 2013 A Presentation from the American Cancer Society
Non-communicable diseases David Redfern
Smoking. { Why Do People Start Smoking? -seem mature -independent -popularity -weight management -media influence -family -curiosity.
Snus as a Substitution for Smoking: The Swedish Experience Lars M. Ramström Institute for tobacco studies Stockholm, Sweden.
Economics of Tobacco Use and Help-Seeking Behavior Bishwa Adhikari, Ph.D., Economist Office on Smoking and Health Centers for Disease Control and Prevention.
Quitting Cigarettes Completely or Switching to Smokeless Tobacco: Do U.S. Data Replicate the Swedish Results? Shu-Hong Zhu University of California, San.
Title : Age at smoking onset, nicotine dependence and their association with smoking temptation among smokers By: Abdurrahman Charkazi, Gholamreza Sharifirad,
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
The impact of the EU accession on Croatia Public health policies on tobacco Marta Čivljak, MD, PHD Research Fellow Department of Medical Sociology and.
Characteristics of new tobacco products emerging on the tobacco market: implications for tobacco control policies Lars M. Ramström Institute for Tobacco.
Global Adult Tobacco Survey (GATS) Funded by Bloomberg Philanthropies.
Smoking cessation aided by low-toxicity smokeless tobacco can save many lives Lars M. Ramström Institute for Tobacco Studies Täby, Sweden UKNSCC 2014 Thursday.
Smokeless Tobacco. Spit tobacco, chewing tobacco, chew, chaw, dip, plug Comes in two forms – Snuf a nicotine containing product made of ground or pulverized.
05-1 Epidemiology of smoking in HCW Smoking epidemiology in smoke- free hospitals Numerous data exists showing that in most European countries, health-care.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Lung Cancer Molecular Pathology of Cancer Boot Camp January 4, 2012 Jennifer Rider, ScD.
The Swedish Quitline Proactive treatment Hans Gilljam & Asgeir Helgason Center for Tobacco Prevention Hans Gilljam CTP 2001 Cancerfonden, Folkhälsoinstitutet,
Number of deaths (’000s) in 1998 attributable to tobacco use WHO Region Males Females World Health Report 1999 All member states3, Africa 112.
FORMS of TOBACCO This module focuses on different forms of tobacco that are available in the U.S.
TOBACCO USE in DIVERSE POPULATIONS. PREVALENCE of ADULT SMOKING, by RACE/ETHNICITY—U.S., 2007 Centers for Disease Control and Prevention. (2008). MMWR.
Prospective Studies (cohort, longitudinal, incidence studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public.
Changes in Patterns of Substance Use ─ Tobacco Lars Ramström Institute for Tobacco Studies Stockholm, Sweden 49th International ICAA Conference on Dependencies.
Population Mortality and Morbidity in Ireland n April 2001.
Ms. Bushong. Stains Teeth, gum disease, tooth loss Fingers turn yellow Ages and wrinkles skin Lung cancer, emphysema, hard to breathe High blood pressure,
Cutting tobacco’s death toll − an overview of different options Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 5th Annual Conference.
Lars M. Ramström PhD Director, Institute for Tobacco Studies Stockholm, Sweden The Swedish experience the role.
The Role of Harm Reduction in Tobacco control – An Update of Pros and Cons Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 53rd International.
Northern Europe Label the following countries on the next page, using the color each countries is labeled in: -United Kingdom (blue) -Ireland (green) -Iceland.
Prevalence of Tobacco Use. Current user: A person who has smoked once in the last 30 days Prevalence of tobacco use: The proportion of current users in.
Oncology in midlife and beyond 2013 Oncology in midlife and beyond.
Who Smokes and Who Quits? (focus on social class) Elizabeth M. Barbeau, ScD, MPH Dana-Farber Cancer Institute Harvard School of Pubic Health.
Epidemiology of Tobacco Use and Cessation Gary A. Giovino, Ph.D., M.S. Roswell Park Cancer Institute Buffalo, New York Consumer Demand Round Table Washington,
Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.
TOBACCOSIS KILLED MORE THAN 100 MILLION WORLDWIDE IN THE 20 th CENTURY!! TOBACCO KILLS.
Ecdc.europa.eu Epidemiological Situation of HIV/AIDS in the EU and its Neighbouring Countries German Presidency Conference Responsibility & Partnership.
TM Substance Use Transitions from Initial Use to Regular Use to Discontinuance Ralph S. Caraballo, Ph.D., MPH Office on Smoking and Health, CDC, Atlanta.
Northern Europe Label the following countries on the next page, using the color each countries is labeled in, then add capitals to each country using a.
Trends in electronic cigarette use in England Robert West Emma Beard Jamie Brown University College London
Cancer inequalities in Europe UKACR & NCIN Conference, 17/18 June 2010 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit Fondazione.
1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.
Smoking in England Robert West Jamie Brown University College London 1.
Date of download: 6/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Polygenic Risk and the Developmental Progression to.
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
EXPOSURE TO TOBACCO SMOKE IN THE EUROPEAN UNION 2nd Working Meeting on Adult Premature Mortality in the European Union October 2006, Warsaw, Poland.
COUNTRY REPORT ON HEALTH STATUS LITHUANIA Jurate Klumbiene Institute for Biomedical Research Kaunas University of Medicine Meeting on adult premature mortality.
DEPENDENCE ON SMOKING Petra Rukavina 6.b. Smoking is a way of consuming tobacco in the form of cigars, cigarettes, cigarillos, and using pipes.
The smoking epidemic and lung cancer in the EU
Rome Cardiology Forum 2014 Update on life-style and cardiovascular prevention The dimension of the problem Rome Cardiology Forum January 29, 2014.
Drug Trends in Sweden 2017 Figures 1–
Trends in use of electronic cigarettes in England
Trends in electronic cigarette use in England
Purposes of a Tobacco-Related Surveillance System
a specific MRTP ─ Snus ─ a low-toxicity oral tobacco product.
Percentage of smokers using cessation aids, percentage achieving abstinence for 3 months and percentage making a quit attempt (the 1992 survey only asked.
Trends in electronic cigarette use in England
Sickness absence as an indicator of health?
RR (with 95% CI) of total mortality (multivariate-adjusted) by duration of smoking cessation among diabetic women. RR (with 95% CI) of total mortality.
Presentation transcript:

Key prevalence data, Sweden (Source: ITS/FSI study 2001/2002) MALES FEMALES (n=3205) (n=3507) Daily Daily Daily Daily smoking snus use smoking snus use 15 % 20 % 19 % 2 %

Tobacco consumption per year in Sweden per person 15 years and older Cigarettes Snus (kg) (kg) Around Around Around

Swedish snus Fine ground tobacco leaves predominantly from air-cured dark tobacco Manufactured by a pasteurizing-like heating process (without any fermentation so as used in most manufacturing procedures for American snuff) ∎ TSNA content: < 5 mg/kg ∎ BaP content: < 10  g/kg (TSNA content of American snuff: mg/kg)

Oral cancer incidence rates per (age standardized to world population) Males in Northern and Western Europé Source: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. Lyon, IARCPress, Countries with highest rates France14.94 Germany13.19 Belgium10.78 Luxembourg10.43 Austria10.39 Countries with lowest rates The Netherlands5.79 Norway5.77 Iceland4.81 Sweden4.52 United Kingdom4.40

Has the use of snus had an influence on the smoking habits in Sweden?

Initiation of tobacco use: Snus, is it a gate leading to smoking, or a vaccination against smoking? Which is the onset rate of smoking in those who have, respectively have not, taken snus as a primary tobacco use?

ONSET RATE OF DAILY SMOKING By presence or absence of primary use of snus All males (n=2756) 40 % With primary snus use (n=397) 20 % Without primary snus use (n=2359) 43 % (Source: ITS/FSI study 2001/2002)

Pathway after start of daily smoking By history of daily use of snus Males Females History of daily use of snus ? Yes No Yes No (n=498) (n=775) (n=84) (n=1240) Still smoking daily17 % 42 % 14 %43 % Red. to occ.nl smo. 12 % 4 % 14 % 6 % Quit smo. compl.71 % 54 % 71 % 51 % (Source: ITS/FSI study 2001/2002)

Cessation aid used at latest quit attempt Kind of aid Males Females (n=447) (n=426) Nicotine gum36 % 55 % Nicotine patch 20 % 42 % Snus 55 % 15 % All other (together)13 % 24 % (Source: ITS/FSI study 2001/2002)

Outcome of latest quit attempt. ( Male ever daily smokers who have used an aid at latest quit attempt) Gum Patch Snus only only only (n=85) (n=41) (n=205) Still smoking daily 44 % 66 % 20 % Red. to occ.nl smo. 11 % 2 % 15 % Quit smo. compl. 46 % 32 % 65 % (Source: ITS/FSI study 2001/2002)

Prevalence of combinations of smoking and use of snus (males) DAILY SMOKING Total (n=3205)15 % Daily smoking AND daily use of snus 2 % Daily smoking AND occasional use of snus 2 % Daily smoking, no use of snus11 % (Source: ITS/FSI study 2001/2002)

MEAN SCORE OF NICOTINE DEPENDENCE (scale from 0 to 2) Users of single aid Gum Patch Snus No aid MEN WOMEN

24 hour systemic intake of nicotine Measured in: users of loose snus (≈ 2g pinches): around 25 mg (same as in smokers of cigarettes per day) Source: Andersson et al 1994, Andersson et al 1997

OVERVIEW OF CESSATION ACHIEVEMENTS Percentage of ever daily Men Women smokers who have … ● continued to smoke daily34%45% cut down to occasional smoking 7% 6% quit completely59%49% Percentage of ever daily snus users who have … ● continued to use snus daily74%65% cut down to occasional snus use 3% 5% quit completely23%30%

SCORES FOR WISH TO QUIT (Scale from 1 to 3) SMOKERS SNUS USERS Men Observed score for wish to quit Women Observed score for wish to quit

Reproduced from: Lunell E.: SRNT Europe 2003

SUMMARY/CONCLUSIONS (1) In Sweden use of snus is more common than smoking among males but less common among females. Use of snus seems to serve as a substitution for smoking thereby contributing to — less initiation of smoking, — more cessation of smoking. Snus seems to be an effective smoking cessation aid and it is commonly used as such by males. Use of snus seems not to result in an ”overload” of nicotine. Use of snus produces nicotine dependence but probably less strongly so than smoking.

SUMMARY/CONCLUSIONS (2) Findings from current studies suggest that snus, although not a ”health product” by itself, can, by serving as a substitution for smoking, be one of the many factors that have contributed to the current situation in Sweden with low smoking rates and accordingly low rates of tobacco-related morbidity and mortality..